Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.

Published in:

Cancer (0008543X), 2024, v. 130, n. 6, p. 876, doi. 10.1002/cncr.35114

By:

• Gordon, Max J.;
• Feng, Lei;
• Strati, Paolo;
• Lee, Hun Ju;
• Hagemeister, Fredrick B.;
• Westin, Jason R.;
• Samaniego, Felipe;
• Marques‐Piubelli, Mario L.;
• Vega Vazquez, Francisco;
• Parra Cuentas, Edwin R.;
• Solis‐Soto, Luisa M.;
• Ma, Wencai;
• Wang, Jing;
• Claret, Linda;
• Averill, Barbara;
• Ibanez, Karina;
• Fayad, Luis E.;
• Flowers, Christopher R.;
• Green, Michael R.;
• Davis, R. Eric

Publication type:

Article